GENinCode Archives | Be Korea-savvy

Positive Results for Lipid inCode® in NHS Clinical Study

OXFORD, England, Feb. 15 (Korea Bizwire) – GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the successful completion of its NHS clinical study and positive results for its Lipid inCode® test (“Lipid inCode®”) for hypercholesterolemia (high levels of cholesterol), including Familial Hypercholesterolemia (FH), undertaken at Royal Brompton and Harefield Hospitals (“RB&H”), [...]

FDA Pre-Submission Filed for Cardio inCode-SCORE

OXFORD, England, Jan. 11 (Korea Bizwire) – GENinCode Plc (AIM: GENI), the predictive genetics company focused on the prevention of cardiovascular disease, announces the filing of its Pre-Submission for Cardio inCode-SCORE with the Food and Drug Administration (FDA). Cardio inCode-SCORE is an in-vitro diagnostic test that assesses an individual’s combined genetic and clinical risk to predict and [...]